Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Drug Screening Market

ID: MRFR/HC/19136-HCR
128 Pages
Vikita Thakur
Last Updated: May 05, 2026
Drug Screening Market Research Report: Size, Share, Trend Analysis By Types (Urine Testing, Saliva Testing, Blood Testing, Hair Testing), By Technology (Immunoassay, Chromatography, Mass Spectrometry, PCR Testing), By End Use (Workplace, Drug Rehabilitation Centers, Hospitals and Clinics, Law Enforcement), By Panel Size (Single Panel, Multi-Panel, Expanded Panel) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Type (USD Billion) | |
      1. 4.1.1 Urine Testing | |
      2. 4.1.2 Saliva Testing | |
      3. 4.1.3 Blood Testing | |
      4. 4.1.4 Hair Testing |
    2. 4.2 Healthcare, BY Technology (USD Billion) | |
      1. 4.2.1 Immunoassay | |
      2. 4.2.2 Chromatography | |
      3. 4.2.3 Mass Spectrometry | |
      4. 4.2.4 PCR Testing |
    3. 4.3 Healthcare, BY End Use (USD Billion) | |
      1. 4.3.1 Workplace | |
      2. 4.3.2 Drug Rehabilitation Centers | |
      3. 4.3.3 Hospitals and Clinics | |
      4. 4.3.4 Law Enforcement |
    4. 4.4 Healthcare, BY Panel Size (USD Billion) | |
      1. 4.4.1 Single Panel | |
      2. 4.4.2 Multi-Panel | |
      3. 4.4.3 Expanded Panel |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Abbott Laboratories (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Thermo Fisher Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Roche Diagnostics (CH) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Siemens Healthineers (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Quest Diagnostics (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Alere Inc. (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 LabCorp (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Bio-Rad Laboratories (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Medtox Scientific (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY TECHNOLOGY |
    8. 6.5 US MARKET ANALYSIS BY END USE |
    9. 6.6 US MARKET ANALYSIS BY PANEL SIZE |
    10. 6.7 CANADA MARKET ANALYSIS BY TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY TECHNOLOGY |
    12. 6.9 CANADA MARKET ANALYSIS BY END USE |
    13. 6.10 CANADA MARKET ANALYSIS BY PANEL SIZE |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
    17. 6.14 GERMANY MARKET ANALYSIS BY END USE |
    18. 6.15 GERMANY MARKET ANALYSIS BY PANEL SIZE |
    19. 6.16 UK MARKET ANALYSIS BY TYPE |
    20. 6.17 UK MARKET ANALYSIS BY TECHNOLOGY |
    21. 6.18 UK MARKET ANALYSIS BY END USE |
    22. 6.19 UK MARKET ANALYSIS BY PANEL SIZE |
    23. 6.20 FRANCE MARKET ANALYSIS BY TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
    25. 6.22 FRANCE MARKET ANALYSIS BY END USE |
    26. 6.23 FRANCE MARKET ANALYSIS BY PANEL SIZE |
    27. 6.24 RUSSIA MARKET ANALYSIS BY TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
    29. 6.26 RUSSIA MARKET ANALYSIS BY END USE |
    30. 6.27 RUSSIA MARKET ANALYSIS BY PANEL SIZE |
    31. 6.28 ITALY MARKET ANALYSIS BY TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY TECHNOLOGY |
    33. 6.30 ITALY MARKET ANALYSIS BY END USE |
    34. 6.31 ITALY MARKET ANALYSIS BY PANEL SIZE |
    35. 6.32 SPAIN MARKET ANALYSIS BY TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
    37. 6.34 SPAIN MARKET ANALYSIS BY END USE |
    38. 6.35 SPAIN MARKET ANALYSIS BY PANEL SIZE |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USE |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PANEL SIZE |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY TECHNOLOGY |
    46. 6.43 CHINA MARKET ANALYSIS BY END USE |
    47. 6.44 CHINA MARKET ANALYSIS BY PANEL SIZE |
    48. 6.45 INDIA MARKET ANALYSIS BY TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY TECHNOLOGY |
    50. 6.47 INDIA MARKET ANALYSIS BY END USE |
    51. 6.48 INDIA MARKET ANALYSIS BY PANEL SIZE |
    52. 6.49 JAPAN MARKET ANALYSIS BY TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
    54. 6.51 JAPAN MARKET ANALYSIS BY END USE |
    55. 6.52 JAPAN MARKET ANALYSIS BY PANEL SIZE |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USE |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PANEL SIZE |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY END USE |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY PANEL SIZE |
    64. 6.61 THAILAND MARKET ANALYSIS BY TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
    66. 6.63 THAILAND MARKET ANALYSIS BY END USE |
    67. 6.64 THAILAND MARKET ANALYSIS BY PANEL SIZE |
    68. 6.65 INDONESIA MARKET ANALYSIS BY TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
    70. 6.67 INDONESIA MARKET ANALYSIS BY END USE |
    71. 6.68 INDONESIA MARKET ANALYSIS BY PANEL SIZE |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY END USE |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY PANEL SIZE |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
    79. 6.76 BRAZIL MARKET ANALYSIS BY END USE |
    80. 6.77 BRAZIL MARKET ANALYSIS BY PANEL SIZE |
    81. 6.78 MEXICO MARKET ANALYSIS BY TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
    83. 6.80 MEXICO MARKET ANALYSIS BY END USE |
    84. 6.81 MEXICO MARKET ANALYSIS BY PANEL SIZE |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY END USE |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY PANEL SIZE |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PANEL SIZE |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USE |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PANEL SIZE |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USE |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PANEL SIZE |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY END USE |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY PANEL SIZE |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY END USE, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY PANEL SIZE, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY PANEL SIZE, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY END USE, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY PANEL SIZE, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Urine Testing
  • Saliva Testing
  • Blood Testing
  • Hair Testing

Healthcare By Technology (USD Billion, 2025-2035)

  • Immunoassay
  • Chromatography
  • Mass Spectrometry
  • PCR Testing

Healthcare By End Use (USD Billion, 2025-2035)

  • Workplace
  • Drug Rehabilitation Centers
  • Hospitals and Clinics
  • Law Enforcement

Healthcare By Panel Size (USD Billion, 2025-2035)

  • Single Panel
  • Multi-Panel
  • Expanded Panel